Since the effects of VIP and PACAP are regulated by VIPRs, various analogs of them are used for the treatment therapies of physiological problems associated with gastrointestinal, immune, reproductive, respiratory, cardiovascular, and endocrine systems, as well as cancer malignancies. The gene discussed is VIP; the disease is cancer.